Des Atouts Changement Date
Cara Therapeutics USD 23.53M 2.28M 2026-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 138.36M 7.5M 2026-06
Cronos Group USD 1.2B 18.15M 2026-09
RedHill Biopharma USD 26.27M 929K 2026-06